The Centers for Disease Control and Prevention and other federal agencies have altered or removed hundreds of pages of HIV-related information on their websites, part of a government-wide purge of ...

The Centers for Disease Control and Prevention (CDC) has come out with a strong recommendation for the use of Gilead Sciences’ twice-yearly HIV pre-exposure prophylaxis (PrEP) med Yeztugo, ...

The Centers for Disease Control and Prevention on Friday is scrubbing a swath of HIV-related content from the agency’s website as a part of President Donald Trump’s broader effort to wipe out ...

People deemed to be at high risk for contracting HIV, the virus that causes AIDS, should take anti-HIV medicines that seem to cut transmission risk, the U.S. Centers for Disease Control and Prevention ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...

The sharp job cuts at the Centers for Disease Control and Prevention include a successful program reducing HIV transmission to babies. Over the past 30 years, the number of infant HIV cases has fallen ...